Correlation Between Artelo Biosciences and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artelo Biosciences and Emergent Biosolutions, you can compare the effects of market volatilities on Artelo Biosciences and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Emergent Biosolutions.
Diversification Opportunities for Artelo Biosciences and Emergent Biosolutions
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Artelo and Emergent is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Artelo Biosciences and Emergent Biosolutions
Given the investment horizon of 90 days Artelo Biosciences is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Artelo Biosciences is 2.7 times less risky than Emergent Biosolutions. The stock trades about -0.01 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 241.00 in Emergent Biosolutions on September 19, 2024 and sell it today you would earn a total of 646.00 from holding Emergent Biosolutions or generate 268.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Artelo Biosciences vs. Emergent Biosolutions
Performance |
Timeline |
Artelo Biosciences |
Emergent Biosolutions |
Artelo Biosciences and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Artelo Biosciences and Emergent Biosolutions
The main advantage of trading using opposite Artelo Biosciences and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.Artelo Biosciences vs. Emergent Biosolutions | Artelo Biosciences vs. Neurocrine Biosciences | Artelo Biosciences vs. Teva Pharma Industries | Artelo Biosciences vs. Haleon plc |
Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |